The MicroInfuser is named but not linked, by editorial choice, so the article's molecular argument can stand on its merits without ambient commercial pressure
Make a log of any suspected triggers
[35] Monti, D.A., Zabrecky, G., Kremens, D., Liang, T., Wintering, N.A., Bazzan, A.J
Lange CE, Jhe S, Stein G, & Veltman G (1974) [The so-called vinyl chloride disease -- an occupational scleroderma?] Int Arch Arbeitsmed, 32: 1-32 (in German)
[DOI] [PMC free article] [PubMed] [Google Scholar] 620
Investigating differential responses based on patient demographics, genetic profiles, and specific pain conditions will also be crucial in developing personalized treatment strategies, thereby optimizing the therapeutic benefits of GLP-1R agonists for diverse patient populations